# Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)

> **NCT01755468** · PHASE3 · COMPLETED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Intermittent insulin therapy
- **DRUG:** Continuous metformin

## Key facts

- **NCT ID:** NCT01755468
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01755468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01755468, "Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01755468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*